Dyne Therapeutics DYN
NASDAQ DYN
$16.11 -0.10 (-0.62%)
At close: Sep 30, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Shares Outstanding (Entity) (2019 - 2026)

Updated

Dyne Therapeutics' Shares Outstanding (Entity) was 165.67 million in Q2 2026, up 44.9% from 114.34 million a year earlier and up 0.3% from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends

For FY2025, Shares Outstanding (Entity) at Dyne Therapeutics came in at 128.44 million, up 25.5% from FY2024.

  • Shares Outstanding (Entity) has now increased for six consecutive years, with a five-year compound annual growth rate of 54.9% (FY2020 to FY2025).
  • In earlier years, Shares Outstanding (Entity) was 102.32 million in FY2024 (+66.5%), 61.47 million in FY2023 (+10.5%), 55.64 million in FY2022 (+7.9%) and 51.57 million in FY2021 (+258.2%).
  • The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2019.
  • Compared with a year earlier, Shares Outstanding (Entity) has increased for 20 straight quarters, with growth averaging 41.6% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.8% (Q3 2022) and 644.0% (Q3 2021) over the last five years.
  • Per Business Quant data, DYN's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 165.2 million (Q1 2026), 128.44 million (Q4 2025) and 142.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 2.41 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 1.77 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 1.24 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 253.35 Mn
10 Dyne Therapeutics 2.69 Bn 2.69 Bn - 165.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 165.67 Mn
Mar 31, 2026 165.20 Mn
Dec 31, 2025 128.44 Mn
Sep 30, 2025 142.61 Mn
Jun 30, 2025 114.34 Mn
Mar 31, 2025 113.63 Mn
Dec 31, 2024 102.32 Mn
Sep 30, 2024 101.75 Mn
Jun 30, 2024 100.12 Mn
Mar 31, 2024 87.09 Mn
Dec 31, 2023 61.47 Mn
Sep 30, 2023 61.32 Mn
Jun 30, 2023 61.01 Mn
Mar 31, 2023 58.31 Mn
Dec 31, 2022 55.64 Mn
Sep 30, 2022 51.91 Mn
Jun 30, 2022 51.73 Mn
Mar 31, 2022 51.65 Mn
Dec 31, 2021 51.57 Mn
Sep 30, 2021 51.48 Mn
API Access

Dyne Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=DYN&period=max&api_key=YOUR_API_KEY